Latest stories on RNAC
Cartesian Therapeutics EPS of $0.46
Seeking Alpha34 · bearishearnings
Cartesian Therapeutics, Inc. (RNAC) files 8-K
SEC 8-K50 · neutralgeneral
Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Business Insider63 · neutralproduct/pr
Cartesian Therapeutics Announces New Employment Inducement Grants | RNAC Stock News
StockTitan50 · neutralgeneral
Cartesian Therapeutics, Inc. (RNAC) files 8-K
SEC 8-K50 · neutralgeneral
Cartesian Therapeutics Announces New Employment Inducement Grant | RNAC Stock News
StockTitan50 · neutralgeneral
RNAC’s Strategic WestGene Partnership Sets Stage for In Vivo CAR-T Advances in Autoimmune Therapy
MarketChameleon67 · bullishproduct/pr
Cartesian climbs on licensing deal with WestGene for CAR-T therapies
Seeking Alpha71 · bullishproduct/pr
Strategic RNAC-WestGene Partnership Targets Next-Gen CAR-T for Autoimmune Diseases
MarketChameleon63 · neutralproduct/pr
Cartesian Therapeutics Announces In Vivo CAR-T Licensing Alliance
TipRanks63 · neutralproduct/pr
Cartesian Therapeutics, Inc. (RNAC) files 8-K
SEC 8-K50 · neutralgeneral
Cartesian Secures Major Loan Facility to Extend Runway
TipRanks58 · neutralgeneral
Bounteous Acquires Cartesian, Enhancing Deep Data and Analytics Capabilities to Accelerate Enterprise AI
PR Newswire62 · neutralm&a